Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis
Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...
What parents should know about kids and caffeine amid rise in ER visits
The study, released Monday by Epic Research, found the number of caffeine-related ER visits for middle school-aged children ...
For people with opioid addiction, Medicaid 'unwinding' raises the stakes
It was hard enough for Stephanie to get methadone treatment when she moved to Florida from Indiana last year. The nearest ...